Biosurgical Products - Overview

Active Hemostats: Liquid Fibrin Sealants

Fibrin sealants are tissue adhesives used by surgeons to stop the bleeding from small blood vessels during surgery when conventional surgical techniques are not feasible. OMRIX is developing a suite of next-generation hemostats that provide surgeons with easy-to-use and effective means to promote hemostasis, or control of bleeding, during surgery. We compete effectively in the active hemostats market with our Evicel™ (in the US) and Quixil® (outside of the US) products, which are fibrin sealants that contain a unique Biologically Active Component, or BAC. We expect this market to grow substantially as there is a need for more effective products. Quixil® is indicated for use as a general adjunct to hemostasis in Europe, Israel and several other countries. Evicel™ is our next generation Fibrin Sealant and is indicated as an adjunct to hemostasis for general surgical use in the US.

Advanced Hemostats: Fibrin patch

In collaboration with Ethicon, a Johnson & Johnson company, we are developing a breakthrough convergence product, the fibrin patch. Our fibrin patch is being developed as a tool to help emergency room and other surgeons stop severe and brisk, including active bleeding that is difficult to control. Fibrin patch will help surgeons heal bleeding wounds in two steps: first by acting as an immediate physiological barrier to stop bleeding; and second, by utilizing a biological component that promotes the rapid formation of a clot at the site of the wound. We believe our fibrin patch has the potential to answer an unmet surgical need, particularly in cases of severe and brisk bleeding.